Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-09-12 Purchase | 2024-09-13 5:43 pm | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO AND PRESIDENT | 14,815 | $5.0867 | $75,359 | 384,677 (Direct) | View |
2024-09-10 Purchase | 2024-09-12 7:06 pm | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO AND PRESIDENT | 5,000 | $4.97 | $24,850 | 369,862 (Direct) | View |
2020-06-22 Sale | 2020-06-24 4:55 pm | Coherus BioSciences Inc. | CHRS | Szela Mary T Director | 54,997 | $17.58 | $966,759 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-06-20 Option Award | 2024-06-21 4:20 pm | N/A 2034-06-19 | Omega Therapeutics Inc. | OMGA | Szela Mary T Director | 25,000 | $0 | 25,000 (Direct) | View |
2024-06-05 Option Award | 2024-06-07 4:30 pm | N/A 2034-06-04 | Kura Oncology Inc. | KURA | Szela Mary T Director | 26,000 | $0 | 26,000 (Direct) | View |
2024-02-13 Option Award | 2024-02-14 6:44 pm | N/A 2034-02-12 | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO AND PRESIDENT | 373,649 | $0 | 653,612 (Direct) | View |
2023-08-14 Option Award | 2023-08-15 4:48 pm | N/A 2033-08-13 | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO and President | 172,500 | $0 | 172,500 (Direct) | View |
Ownership | 2023-08-15 4:46 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO and President | 0 | $0 | 906,895 (Direct) | View |
2023-06-16 Disposition | 2023-06-16 4:00 pm | N/A 2031-03-10 | Prometheus Biosciences Inc. | RXDX | Szela Mary T Director | 62,571 | $0 | 0 (Direct) | View |
2023-06-07 Option Award | 2023-06-09 4:05 pm | N/A 2033-06-06 | Omega Therapeutics Inc. | OMGA | Szela Mary T Director | 18,118 | $0 | 18,118 (Direct) | View |
2023-05-31 Option Award | 2023-06-02 5:02 pm | N/A 2033-05-30 | Kura Oncology Inc. | KURA | Szela Mary T Director | 26,000 | $0 | 26,000 (Direct) | View |
2023-05-19 Option Award | 2023-05-19 5:47 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | Szela Mary T Director | 2,071 | $0 | 2,071 (Direct) | View |
2022-06-21 Option Award | 2022-06-23 4:49 pm | N/A 2032-06-20 | Kura Oncology Inc. | KURA | Szela Mary T Director | 23,000 | $0 | 23,000 (Direct) | View |
2022-06-08 Option Award | 2022-06-10 4:10 pm | N/A 2032-06-07 | Omega Therapeutics Inc. | OMGA | Szela Mary T Director | 18,118 | $0 | 18,118 (Direct) | View |
2022-05-19 Option Award | 2022-05-20 7:30 pm | N/A 2032-05-18 | Prometheus Biosciences Inc. | RXDX | Szela Mary T Director | 20,500 | $0 | 20,500 (Direct) | View |
Ownership | 2021-07-29 9:01 pm | N/A 2029-09-16 | Omega Therapeutics Inc. | OMGA | Szela Mary T Director | 0 | $0 | 83,826 (Direct) | View |
2021-06-22 Option Award | 2021-06-23 5:19 pm | N/A 2031-06-21 | Kura Oncology Inc. | KURA | Szela Mary T Director | 23,000 | $0 | 23,000 (Direct) | View |
2021-03-11 Option Award | 2021-03-11 9:47 pm | N/A 2031-03-10 | Prometheus Biosciences Inc. | RXDX | Szela Mary T Director | 40,000 | $0 | 40,000 (Direct) | View |
2021-01-11 Option Award | 2021-01-13 4:29 pm | N/A 2031-01-11 | Coherus BioSciences Inc. | CHRS | Szela Mary T Director | 20,000 | $0 | 20,000 (Direct) | View |
2020-06-24 Option Award | 2020-06-26 4:10 pm | N/A 2030-06-23 | Kura Oncology Inc. | KURA | Szela Mary T Director | 23,000 | $0 | 23,000 (Direct) | View |
2020-06-22 Exercise | 2020-06-24 4:55 pm | N/A 2024-06-30 | Coherus BioSciences Inc. | CHRS | Szela Mary T Director | 54,997 | $0 | 0 (Direct) | View |
2020-06-22 Exercise | 2020-06-24 4:55 pm | N/A N/A | Coherus BioSciences Inc. | CHRS | Szela Mary T Director | 20,000 | $12.37 | 0 (Direct) | View |
2020-06-22 Exercise | 2020-06-24 4:55 pm | N/A N/A | Coherus BioSciences Inc. | CHRS | Szela Mary T Director | 20,000 | $10.05 | 0 (Direct) | View |
2020-06-22 Exercise | 2020-06-24 4:55 pm | N/A N/A | Coherus BioSciences Inc. | CHRS | Szela Mary T Director | 14,997 | $2.5005 | 0 (Direct) | View |
2020-06-18 Option Award | 2020-06-22 4:18 pm | N/A 2030-06-17 | ALIMERA SCIENCES INC | ALIM | Szela Mary T Director | 3,333 | $0 | 3,333 (Direct) | View |
2020-01-10 Option Award | 2020-01-14 5:54 pm | N/A 2030-01-10 | Coherus BioSciences Inc. | CHRS | Szela Mary T Director | 20,000 | $0 | 20,000 (Direct) | View |